Published: Oct 26, 2021, 19:30 IST | Updated: Oct 26, 2021, 19:30 IST
The World Health Organization (WHO) seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct a final 'risk-benefit assessment' for emergency use listing of the vaccine.